Status:
UNKNOWN
Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid Patients Associated With Neuropsychological Manifestations.
Lead Sponsor:
Assiut University
Conditions:
Covid Patients
Eligibility:
All Genders
2-80 years
Brief Summary
Measurement of Beta endorphins,interleukin 1 and interleukin 38 in covid patients associated with neuropsychological manifestations.
Detailed Description
The world is facing one of its worst infectious disease pandemics in history, i.e., Covid-19. Coronavirus, SARS-CoV-2 was identified as the cause of an outbreak of a severe pneumonia-like disease, cur...
Eligibility Criteria
Inclusion
- Patients had positive throat swab. Patients had chest finding on CT
Exclusion
- Other respiratory diseases
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05198388
Start Date
March 1 2023
End Date
March 30 2024
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt